Iron bioavailability from commercially available iron supplements
- 1.2k Downloads
Iron deficiency anaemia (IDA) is a global public health problem. Treatment with the standard of care ferrous iron salts may be poorly tolerated, leading to non-compliance and ineffective correction of IDA. Employing supplements with higher bioavailability might permit lower doses of iron to be used with fewer side effects, thus improving treatment efficacy. Here, we compared the iron bioavailability of ferrous sulphate tablets with alternative commercial iron products, including three liquid-based supplements.
Iron bioavailability was measured using Caco-2 cells with ferritin formation as a surrogate marker for iron uptake. Statistical analysis was performed using one-way ANOVA followed by either Dunnett’s or Tukey’s multiple comparisons tests.
Spatone Apple® (a naturally iron-rich mineral water with added ascorbate) and Iron Vital F® (a synthetic liquid iron supplement) had the highest iron bioavailability. There was no statistical difference between iron uptake from ferrous sulphate tablets, Spatone® (naturally iron-rich mineral water alone) and Pregnacare Original® (a multimineral/multivitamin tablet).
In our in vitro model, naturally iron-rich mineral waters and synthetic liquid iron formulations have equivalent or better bioavailability compared with ferrous iron sulphate tablets. If these results are confirmed in vivo, this would mean that at-risk groups of IDA could be offered a greater choice of more bioavailable and potentially better tolerated iron preparations.
KeywordsIron supplements Anaemia Pregnancy Bariatric surgery Micronutrient deficiency Caco-2 cells
This work was supported by the Faculty of Engineering and Science at the University of Greenwich, and the Diabetes and Nutritional Sciences Division at King’s College London. We thank David Scott Ganis for assistance with statistical and numerical analysis.
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- 7.Hyder SM, Persson LA, Chowdhury AM, Ekstrom EC (2002) Do side-effects reduce compliance to iron supplementation? A study of daily- and weekly-dose regimens in pregnancy. J Health Popul Nutr 20(2):175–179Google Scholar
- 12.Beard JL (2000) Effectiveness and strategies of iron supplementation during pregnancy. Am J Clin Nutr 71(5 Suppl):1288S–1294SGoogle Scholar
- 13.Ekstrom EC, Kavishe FP, Habicht JP, Frongillo EA Jr, Rasmussen KM, Hemed L (1996) Adherence to iron supplementation during pregnancy in Tanzania: determinants and hematologic consequences. Am J Clin Nutr 64(3):368–374Google Scholar
- 18.Glahn RP, Lee OA, Yeung A, Goldman MI, Miller DD (1998) Caco-2 cell ferritin formation predicts nonradiolabeled food iron availability in an in vitro digestion/Caco-2 cell culture model. J Nutr 128(9):1555–1561Google Scholar
- 19.Yun S, Habicht JP, Miller DD, Glahn RP (2004) An in vitro digestion/Caco-2 cell culture system accurately predicts the effects of ascorbic acid and polyphenolic compounds on iron bioavailability in humans. J Nutr 134(10):2717–2721Google Scholar
- 24.Motulsky H (2010) Intuitive biostatistics, 2nd edn. Oxford University Press, OxfordGoogle Scholar
- 28.Scholl TO (2005) Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 81(5):1218S–1222SGoogle Scholar
- 29.CDC (1998) Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep, vol 47. Centers for Disease Control and PreventionGoogle Scholar
- 30.WHO (World Health Oreganization) (2012) Guideline: daily iron and folic acid supplementation in pregnant women. Geneva, World Health OrganizationGoogle Scholar
- 31.WHO (World Health Organization) (2012) Guideline: intermittent iron and folic acid supplementation in non-anaemic pregnant women. Geneva, World Health OrganizationGoogle Scholar
- 32.NICE (2008) Antenatal care: routine care for the healthy pregnant woman. National Institute for Clinical Excellence, LondonGoogle Scholar
- 43.Gasteyger C, Suter M, Gaillard RC, Giusti V (2008) Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr 87(5):1128–1133Google Scholar
- 45.Clements RH, Katasani VG, Palepu R, Leeth RR, Leath TD, Roy BP, Vickers SM (2006) Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting. Am Surg 72(12):1196–1202Google Scholar
- 47.Fairweather-Tait S, Lynch S, Hotz C, Hurrell R, Abrahamse L, Beebe S, Bering S, Bukhave K, Glahn R, Hambidge M, Hunt J, Lonnerdal B, Miller D, Mohktar N, Nestel P, Reddy M, Sandber AS, Sharp P, Teucher B, Trinidad TP (2005) The usefulness of in vitro models to predict the bioavailability of iron and zinc: a consensus statement from the HarvestPlus expert consultation. Int J Vitam Nutr Res 75(6):371–374CrossRefGoogle Scholar